UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine

Pharmaceutics, 2023-04, Vol.15 (4), p.1139

2023

Volltextzugriff (PDF)

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Journal of the American Geriatrics Society (JAGS), 2008-07, Vol.56 (7), p.1333-1341

2008

Volltextzugriff (PDF)

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Schizophrenia bulletin, 2013-05, Vol.39 (3), p.564-574

2013

Volltextzugriff (PDF)

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

Clinical and translational science, 2019-09, Vol.12 (5), p.519-528

2019

Volltextzugriff (PDF)

exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity

Cancer chemotherapy and pharmacology, 2011-01, Vol.67 (1), p.93-101

2011

Volltextzugriff (PDF)

Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials

Clinical and translational science, 2021-09, Vol.14 (5), p.1864-1874

2021

Volltextzugriff (PDF)

Sex, Race, and Smoking Impact Olanzapine Exposure

Journal of clinical pharmacology, 2008-02, Vol.48 (2), p.157-165

2008

Volltextzugriff (PDF)

Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients

The AAPS journal, 2020-03, Vol.22 (3), p.59, Article 59

2020

Volltextzugriff (PDF)

Modelling the progression of illicit substance use patterns from real‐world evidence

British journal of clinical pharmacology, 2024-03, Vol.90 (3), p.700-712

2024

Volltextzugriff (PDF)

A model of anticholinergic activity of atypical antipsychotic medications

Schizophrenia research, 2006-12, Vol.88 (1), p.63-72

2006

Volltextzugriff (PDF)

Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study

Schizophrenia research, 2015-05, Vol.164 (1), p.149-154

2015

Volltextzugriff (PDF)

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

British journal of clinical pharmacology, 2008-11, Vol.66 (5), p.629-639

2008

Volltextzugriff (PDF)

Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability

CPT: pharmacometrics and systems pharmacology, 2024-06

2024

Volltextzugriff (PDF)

Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis

Pharmacopsychiatry, 2024-03, Vol.57 (2), p.53-60

2024

Volltextzugriff (PDF)

Evaluation of ChatGPT and Gemini large language models for pharmacometrics with NONMEM

Journal of pharmacokinetics and pharmacodynamics, 2024-06, Vol.51 (3), p.187-197

2024

Volltextzugriff (PDF)

Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach

PloS one, 2013-09, Vol.8 (9), p.e73361-e73361

2013

Volltextzugriff (PDF)

Authors’ response to letter to editor

Journal of pharmacokinetics and pharmacodynamics, 2024-08, Vol.51 (4), p.305-305

2024

Volltextzugriff (PDF)

A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance

The Journal of pharmacology and experimental therapeutics, 2022-12, Vol.383 (3), p.217-226

2022

Volltextzugriff (PDF)

Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: An updated review

Gender medicine, 2009-12, Vol.6 (4), p.522-543

2009

Volltextzugriff (PDF)

Age and Sex Impact Clozapine Plasma Concentrations in Inpatients and Outpatients With Schizophrenia

The American journal of geriatric psychiatry, 2012, Vol.20 (1), p.53-60

2012

Volltextzugriff (PDF)

Translocator Protein Blockade Reduces Prostate Tumor Growth

Clinical cancer research, 2009-10, Vol.15 (19), p.6177-6184

2009

Volltextzugriff (PDF)

Preface to Special Issue for Panos Macheras

Journal of pharmacokinetics and pharmacodynamics, 2019-04, Vol.46 (2), p.103-103

Bies, Robert R.

2019

Volltextzugriff (PDF)

Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial

Journal of clinical psychopharmacology, 2019-07, Vol.39 (4), p.329-335

2019

Volltextzugriff (PDF)

Perspectives on the past, present, and future of pharmacometrics

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1403-1405

2022

Volltextzugriff (PDF)

Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach

PloS one, 2014-01, Vol.9 (1)

2014

Volltextzugriff (PDF)

1 – 25 von 150

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Englisch
(150)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Humans
(94)
Life Sciences & Biomedicine
(94)
Male
(66)
Female
(64)
Pharmacology & Pharmacy
(63)
Adult
(52)
Middle Aged
(52)
Aged
(41)
Biological And Medical Sciences
(41)
Medical Sciences
(36)
Pharmacology. Drug Treatments
(30)
Psychiatry
(28)
Pharmacokinetics
(26)
Models, Biological
(21)
Schizophrenia - Drug Therapy
(21)
Social Sciences
(20)
Adolescent
(19)
Psychology. Psychoanalysis. Psychiatry
(19)
Schizophrenia
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deep Learning Methods Applied to Drug Concentration Prediction of Olanzapine

Anticholinergic Activity of 107 Medications Commonly Used by Older Adults

Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data

Prediction of Nephropathy in Type 2 Diabetes: An Analysis of the ACCORD Trial Applying Machine Learning Techniques

exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity

Application of machine learning to predict reduction in total PANSS score and enrich enrollment in schizophrenia clinical trials

Sex, Race, and Smoking Impact Olanzapine Exposure

Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients

Modelling the progression of illicit substance use patterns from real‐world evidence

A model of anticholinergic activity of atypical antipsychotic medications

Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

Simulating realistic patient profiles from pharmacokinetic models by a machine learning postprocessing correction of residual variability

Unraveling the Influence of Age, IQ, Education, and Negative Symptoms on Neurocognitive Performance in Schizophrenia: A Conditional Inference Tree Analysis

Evaluation of ChatGPT and Gemini large language models for pharmacometrics with NONMEM

Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach

Authors’ response to letter to editor

A Physiologically-Based Pharmacokinetic Model of the Brain Considering Regional Lipid Variance

Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: An updated review

Age and Sex Impact Clozapine Plasma Concentrations in Inpatients and Outpatients With Schizophrenia

Translocator Protein Blockade Reduces Prostate Tumor Growth

Preface to Special Issue for Panos Macheras

Model-Guided Antipsychotic Dose Reduction in Schizophrenia: A Pilot, Single-Blind Randomized Controlled Trial

Perspectives on the past, present, and future of pharmacometrics

Correction: Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach

Suchergebnisse filtern